Health Condition 1: D352- Benign neoplasm of pituitary gland
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All adult patients scheduled for elective endoscopic Trans-nasal Trans-sphenoidal approach for resection of pituitary tumor will be included in the study.
Exclusion criteria
Exclusion criteria: Patients who refuse to give consent, Pre-exisiting Uncontrolled hypertension and diabetes, Coagulopathy or bleeding tendency, Pre-operative Glasgow Coma Scale <15, those who receive dexmedetomidine infusions intraoperatively
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the intra-operative pain (using Analgesia Nociceptive Index) and opioid consumption in patients undergoing Endoscopic Trans-nasal Trans-sphenoidal Resection of pituitary tumors receiving bilateral USG guided SPG block vs no block.Timepoint: Data (HR, MAP, SPI, ANIi and ANIm) will be collected every minute for five minutes (T1 T5) prior to and after the noxious stimuli during surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To compare intra-operative Analgesia Nociception Index (ANI) & Surgical Pleth Index (SPI) with the hemodynamic parameters at various stages of noxious stimulus within the group & between the groups. 2) To compare rescue analgesia between the groups during intraoperative period & up to 48 hours after the surgery. 3) To compare the adverse events between the groups (Intraoperative Bleeding, delayed recovery, PONV) 4) To compare the recovery characteristics at PACU between the groups (modified Aldrette score) & Pain score- NRSTimepoint: NSR will be assessed at immediate post-op, 4 hours, 24 hours & 48 hours | — |
Countries
India
Contacts
National Institute of Mental Health and Neuro Sciences